130 related articles for article (PubMed ID: 7863255)
1. Effect of nizatidine versus ranitidine on gastric intraluminal prostaglandin release in duodenal ulcer patients.
Silecchia G; Spaziani E; Guarino E; Neri T; Grasso E; Mariani P; Materia A; Genco A; Basso N
Scand J Gastroenterol Suppl; 1994; 206():8-13. PubMed ID: 7863255
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
Park SM; Park J; Chang SK; Yoo BC; Kim HJ
Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
[TBL] [Abstract][Full Text] [Related]
3. Mucosal expression and luminal release of epidermal and transforming growth factors in patients with duodenal ulcer before and after eradication of Helicobacter pylori.
Konturek PC; Ernst H; Konturek SJ; Bobrzyński AJ; Faller G; Klingler C; Hahn EG
Gut; 1997 Apr; 40(4):463-9. PubMed ID: 9176072
[TBL] [Abstract][Full Text] [Related]
4. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
[TBL] [Abstract][Full Text] [Related]
5. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Labenz J; Tillenburg B; Peitz U; Verdú E; Stolte M; Börsch G; Blum AL
Gut; 1997 Jul; 41(1):33-6. PubMed ID: 9274468
[TBL] [Abstract][Full Text] [Related]
6. Peptic ulcer in the elderly--a double-blind, short-term study comparing nizatidine 300 mg with ranitidine 300 mg. GISU (Interdisciplinary Ulcer Study Group).
Battaglia G; Di Mario F; Vigneri S; Dal Santo P; Pilotto A; Mazzacca G
Aliment Pharmacol Ther; 1993 Dec; 7(6):643-8. PubMed ID: 8161671
[TBL] [Abstract][Full Text] [Related]
7. Twice daily nizatidine or ranitidine is superior to once daily dosing in elevating 24 h intragastric pH in patients with duodenal ulcer disease.
Thomson AB; Mahachai V; Bailey RJ; Kirdeikis P; Zuk L; Marriage B; Simpson I; Jamali F
J Gastroenterol Hepatol; 1996 Dec; 11(12):1171-6. PubMed ID: 9034938
[TBL] [Abstract][Full Text] [Related]
8. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Lo WC; Lin HJ; Wang K; Perng CL; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Mar; 59(3):171-6. PubMed ID: 9198292
[TBL] [Abstract][Full Text] [Related]
9. Increased risk for Helicobacter pylori recurrence by continuous acid suppression: a randomized controlled study.
Manes G; Domínguez-Muñoz JE; Uomo G; Labenz J; Hackelsberger A; Malfertheiner P
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):28-33. PubMed ID: 9615260
[TBL] [Abstract][Full Text] [Related]
10. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study.
Di Mario F; Battaglia G; Saggioro A; Chiozzini P; D'Angelo A; Marin R; Morelli A; Vezzadini P; Buscarini L; Cavassini G
Ital J Gastroenterol; 1991 Jun; 23(5):253-6. PubMed ID: 1742515
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor and transforming growth factor alpha in duodenal ulcer and non-ulcer dyspepsia patients before and after Helicobacter pylori eradication.
Konturek PC; Bobrzynski A; Konturek SJ; Bielanski W; Faller G; Kirchner T; Hahn EG
Scand J Gastroenterol; 1998 Feb; 33(2):143-51. PubMed ID: 9517524
[TBL] [Abstract][Full Text] [Related]
12. Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Goggin PM; Marrero JM; Spychal RT; Jackson PA; Corbishley CM; Northfield TC
Gastroenterology; 1992 Nov; 103(5):1486-90. PubMed ID: 1426866
[TBL] [Abstract][Full Text] [Related]
13. The effect of nizatidine on duodenal ulcer healing and on mucosal inflammatory mediators.
Eliakim R; Stalnikowicz R; Ackerman Z; Karmeli F; Rachmilewitz D
Isr J Med Sci; 1994 Oct; 30(10):751-6. PubMed ID: 7960687
[TBL] [Abstract][Full Text] [Related]
14. Eradication of Helicobacter pylori and gastrin-somatostatin link in duodenal ulcer patients.
Konturek JW; Bielański W; Konturek SJ; Domschke W
J Physiol Pharmacol; 1996 Mar; 47(1):161-75. PubMed ID: 8777296
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of tetracycline and metronidazole alone or with ranitidine on the healing of duodenal ulcer and eradication of Helicobacter pylori. A randomized controlled multicenter study. Tetra-Metro-Ran Study Group.
Massarrat S; Ihm P; Koch HK
Arzneimittelforschung; 1998 Jun; 48(6):686-90. PubMed ID: 9689428
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori and impaired gastric secretory functions associated with duodenal ulcer and atrophic gastritis.
Konturek PC; Konturek SJ; Bobrzyński A; Kwiecień N; Obtułowicz W; Stachura J; Hahn EG; Rembiarz K
J Physiol Pharmacol; 1997 Sep; 48(3):365-73. PubMed ID: 9376619
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Bobrzyński A; Gedliczka O; Bielański W; Stachura J; Konturek S; Budzyński A
Wiad Lek; 1997; 50 Suppl 1 Pt 2():340-4. PubMed ID: 9424900
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group.
Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD
Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947
[TBL] [Abstract][Full Text] [Related]
19. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V
Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924
[TBL] [Abstract][Full Text] [Related]
20. [Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Gisbert JP; Boixeda D; Alvarez Baleriola I; Redondo C; De Rafael L; Martín de Argila C; Hernández Ranz F
Rev Esp Enferm Dig; 1995 Apr; 87(4):281-7. PubMed ID: 7794634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
